Catalyst Wire Dossier Catalyst Wire Dossier

dabigatran (Pradaxa)

dabigatran · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for dabigatran (Pradaxa), covering 2018-03-30 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran

See pricing